At the Adult Histiocyte Disorders Center at Dana-Farber Brigham Cancer Center, our mission is to combine world-class patient care with leading-edge research – to provide highly effective, personalized treatment options for patients with adult histiocytosis and histiocyte disorders – a group of rare diseases resulting from the over-production of white blood cells (histiocytes), which can lead to tumors and organ damage.
As part of Dana-Farber Brigham Cancer Center's Hematologic Oncology Treatment Center, the Adult Histiocyte Disorders Center is staffed by a multidisciplinary team of leading medical oncologists, pathologists, surgical oncologists, endocrinologists, cardiologists, nephrologists, neurologists, pulmonologists, orthopedists, dermatologists, and other specialists dedicated to producing the best possible results for patients with histiocyte disorders.
At the Adult Histiocyte Disorders Center at Dana-Farber Brigham Cancer Center, our goal is to optimize care by applying our scientific and clinical knowledge to each individual patient. We continually build on our knowledge base – analyzing outcomes we've achieved with existing treatments, and also developing new treatments.
Ours is the first dedicated adult histiocytosis center in the United States. And as one of the world's largest and most experienced centers for the treatment of adult histiocytosis and histiocyte disorders, we offer the very latest therapies and clinical trials that may not be available elsewhere. We are leaders in clinical trials and scientific collaborations aimed at developing new treatments for these very rare conditions.
Our Center utilizes all the institutional resources and expertise of Dana-Farber Brigham Cancer Center's Hematologic Oncology Treatment Center, including:
- Experienced nurses to administer our advanced treatments
- Experts from nutrition, integrative therapies, social work, and other supportive services
- The advanced research resources of the Hematologic Oncology Treatment Center, such as gene profiling, xenograft models, and other tools
Dedicated to advancing the way histiocyte disorders are diagnosed and treated, our Center's renowned clinical team provides timely, compassionate, and comprehensive multidisciplinary care across the full spectrum of cancer services.